SPECTRAL MEDICAL INC (EDT.CA) Forecast, Price Target & Analyst Ratings

TSX:EDT • CA8475771033

Current stock price

1.38 CAD
-0.02 (-1.43%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SPECTRAL MEDICAL INC (EDT.CA).

Forecast Snapshot

Consensus Price Target

Price Target
CA$3.21
+ 132.83% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 8, 2026
Period
Q1 / 2026
EPS Estimate
-CA$0.01
Revenue Estimate
761.54K
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
83.33%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
CA$3.21
Upside
+ 132.83%
From current price of CA$1.38 to mean target of CA$3.21, Based on 6 analyst forecasts
Low
CA$2.83
Median
CA$3.21
High
CA$3.68

Price Target Revisions

1 Month
1.61%
3 Months
1.61%

Price Target Summary

6 Wall Street analysts provided a forecast for the next 12 months for EDT.CA. The average price target is 3.21 CAD. This implies a price increase of 132.83% is expected in the next year compared to the current price of 1.38.
The average price target has been revised upward by 1.61% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

EDT Current Analyst RatingEDT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

EDT Historical Analyst RatingsEDT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 1 2 3 4 5

Analyst Ratings Consensus

ChartMill Buy Consensus
83.33%
EDT.CA was analyzed by 6 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about EDT.CA.
In the previous month the buy percentage consensus was at a similar level.
EDT.CA was analyzed by 6 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 8, 2026
Period
Q1 / 2026
EPS Estimate
-CA$0.01
Revenue Estimate
761.54K
Revenue Q2Q
36.81%
EPS Q2Q
75.81%
Number of Analysts
2

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
N/A

Next Earnings Summary

EDT.CA is expected to report earnings on 5/8/2026. The consensus EPS estimate for the next earnings is -0.01 CAD and the consensus revenue estimate is 761.54K CAD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
EDT.CA revenue by date.EDT.CA revenue by date.
1.598M
-4.31%		2.286M
43.05%		2.442M
6.82%		5.035M
106.18%		13.887M
175.81%		48.266M
247.56%		158.17M
227.70%		220.71M
39.54%		280.51M
27.09%		344.24M
22.72%		431.1M
25.23%
EBITDA
YoY % growth
EDT.CA ebitda by date.EDT.CA ebitda by date.
-11.518M
-40.98%		-12.49M
-8.44%		-6.315M
49.44%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
EDT.CA ebit by date.EDT.CA ebit by date.
-11.736M
-38.89%		-12.741M
-8.56%		-6.565M
48.47%		-5.732M
12.68%		2.482M
143.30%		49.416M
1,890.98%		98.869M
100.07%		141.73M
43.35%		182.86M
29.02%		226.59M
23.91%		286.38M
26.39%
Operating Margin
EDT.CA operating margin by date.EDT.CA operating margin by date.
-734.42%-557.35%-268.84%-113.85%17.87%102.38%62.51%64.22%65.19%65.82%66.43%
EPS
YoY % growth
EDT.CA eps by date.EDT.CA eps by date.
-0.06
-42.70%		N/A
-23.87%		-0.15
-118.69%		-0.04
73.87%		0.00
100.00%		0.070.20
181.43%		0.33
65.03%		0.45
36.36%		0.57
26.66%		0.74
29.83%

All data in CAD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.01
75.81%		-0.01-0.01
91.05%		-0.01
Revenue
Q2Q % growth		761.54K
36.81%		610.04K
-24.70%		610.04K
-11.75%		715.08K
87.19%
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-1.766M
52.79%		-2.853M
-587.74%		-2.288M
-146.51%		-1.729M
30.22%

All data in CAD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

EDT.CA Yearly Revenue VS EstimatesEDT.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100M 200M 300M 400M
EDT.CA Yearly EPS VS EstimatesEDT.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2028 2029 2030 2031 2032 2033 0 0.2 0.4 0.6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
34.94%
EPS Next 5 Year
32.76%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
163.87%
Revenue Next 5 Year
142.59%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

SPECTRAL MEDICAL INC / EDT.CA Forecast FAQ

What is the average price target for SPECTRAL MEDICAL INC (EDT.CA) stock?

6 analysts have analysed EDT.CA and the average price target is 3.21 CAD. This implies a price increase of 132.83% is expected in the next year compared to the current price of 1.38.

Can you provide the upcoming earnings date for SPECTRAL MEDICAL INC?

SPECTRAL MEDICAL INC (EDT.CA) will report earnings on 2026-05-08.

What are the consensus estimates for SPECTRAL MEDICAL INC (EDT.CA) next earnings?

The consensus EPS estimate for the next earnings of SPECTRAL MEDICAL INC (EDT.CA) is -0.01 CAD and the consensus revenue estimate is 761.54K CAD.

How do analysts rate SPECTRAL MEDICAL INC (EDT.CA)?

The consensus rating for SPECTRAL MEDICAL INC (EDT.CA) is 83.3333 / 100 . This indicates that analysts generally have a positive outlook on the stock.